SUMMARY A total of 17 hypertensive patients suspected of having a pheochromocytoma underwent venous catheterization to determine their free and conjugated plasma catecholamines (CA). Six of the patients were found to have a pheochromocytoma; the seventh, an adrenomedullary hyperplasia. The venous outflow from the site adjacent to toe tumor, when compared to the respective site of sampling in essential hypertensive patients, was characterized by a very high outflow of free (and sometimes an absence of conjugated) CA that resulted in an abnormally high ratio of free-to-conjugated CA; the CA conjugates themselves were rarely elevated. Venous sampling at the peripheral site showed that at the height of the paroxysms, the peripheral venous system in these patients was flooded by free norepinephrine (NE) or epinephrine (E); and by free dopamlne (DA) in another patient who had low blood pressure. The three patients with the most peripheral "flooding" by free CA at the height of the paroxysm had, even In toe normotensive phase, lower conjugated plasma NE + E (p < 0. efficient means of inactivation of catecholamines (CA) released at the nerve terminals; its extent is demonstrated by the finding that 80% of the total norepinephrine plus epinephrine (NE + E) and almost 100% of total dopamine (DA) circulate in conjugated form. 1 The sites of conjugation of the released CA have been uncertain. Thus, we felt it
C ONJUGATION constitutes one of the very efficient means of inactivation of catecholamines (CA) released at the nerve terminals; its extent is demonstrated by the finding that 80% of the total norepinephrine plus epinephrine (NE + E) and almost 100% of total dopamine (DA) circulate in conjugated form. 1 The sites of conjugation of the released CA have been uncertain. Thus, we felt it important to determine from which part of the sympathetic nervous system CA are released free, where they are conjugated (primarily sulfated in man 1 ), and whether this knowledge would be of benefit in diagnosing some forms of hypertension.
A newly developed method of hydrolysis of conjugated CA 1 enabled us to determine circulating free and conjugated CA. The concentration gradients of free and conjugated CA along the normal venous flow were of particular interest in relation -to the "secretory" patterns of the adrenal medulla. The medulla represents the only accumulation of chromaffin tissue from which we can measure the release of E, and to a lesser degree NE, into the venous system. The adrenal medulla is also the most common site of a pheochromocytoma; thus, regional changes of plasma CA and their degree of conjugation could be complementary to the usual determinations of plasma VOL 2, No 2, MARCH-APRIL 1980 free CA in the detection of these tumors. Therefore, the aims of this study were to establish: 1) the patterns of free and conjugated CA in hypertensive patients in whom pheochromocytomas could be eliminated; and 2) whether deviations from these patterns could be a useful tool to study mechanisms of CA release, degradation, and correlation with the clinical presentation of pheochromocytomas.
Material and Methods
Seventeen hypertensive patients, 11 men and six women, underwent venous catheterization in the search for pheochromocytomas (table 1) . Signs and symptoms included hypertensive paroxysms and/or biochemical evidence such as elevated excretion of vanillylmandelic acid (VMA) (seven patients), elevation of urinary CA (10 patients), and a positive intravenous (i.v.) glucagon test that produced an extreme, transitory elevation of blood pressure and an increase in free plasma NE + E 3 minutes after administration of the glucagon (two patients).
No patient had been receiving antihypertensive medication for at least 5 days, or longer acting drugs such as Rauwolfia, guanethidine, or a-methyl dopa for at least 1 month before the study. The patients had been fasting for 12 hours prior to the investigation. In control experiments, 12 hours' fasting has been shown to be sufficient to eliminate dietary effects on plasma conjugates. 1 Alpha-or /8-blocking treatment was not given routinely but was prepared on a standby basis in case of a paroxysm.
After percutaneous catheterization of the femoral vein, under visual control, with a small volume of injected contrast substance (Hypaque-M, 75%), 10 ml of blood was drawn from the following sites: superior vena cava, suprarenal portion (below the ostium of the hepatic veins) of the inferior vena cava, right and left renal veins, left adrenal vein, and the infrarenal portion of the inferior vena cava. Finally, a peripheral venous sample and in some cases an arterial sample were collected. The time difference between individual samplings usually did not exceed 1 minute. While catheterization of the left adrenal vein can usually be performed without difficulty, catheterization of the right adrenal vein failed for anatomical reasons in all but two patients.
The samples were kept on ice and centrifuged within 5 minutes after sampling at 5000 g for 15 minutes at 4°C. The plasma was poured into cooled plastic vials containing sodium metabisulfite (0.5 mg/ml) as an antioxidant, frozen, and stored at -80°C until analysis. After deproteinization with 3N perchloric acid containing 1% EGTA, conjugated CA were hydrolyzed by lyophilization as previously described. 1 The content of CA was determined in duplicate by the radioenzymatic assay of Coyle and Henry, 4 with S-adenosyl-L-methionine (methyl-'H, New England Nuclear) as a methyl donor. In 28 samples, NE and E were determined by the method of Da Prada and Zflrcher, 6 which gave comparable results with that of Coyle and Henry. 4 Internal standards were added to the duplicate specimens. There was a cross reactivity of approximately 1% between DA and E but no cross reactivity between DA and NE. Urinary CA were determined by the method of Coyle and Henry 4 or by that of Anton and Sayre;" the interassay coefficient of correlation was 0.99 for DA and 0.97 for NE and E determination (both p < 0.001). In some samples, VMA 7 and metanephrines" were also determined. Differences between values obtained at several sites of sampling were analyzed using Student's / test. The essential hypertensive patients were considered as one group.
Results
In the final evaluation, surgery confirmed that six of the 16 patients had a pheochromocytoma, and one an adrenal medullary hyperplasia (table 1) . Four patients with pheochromocytomas (Patients 11-13 and 16) had typical, predominantly NE-producing tumors; Patient 14, described in detail elsewhere, 9 had atypical, predominantly normotensive crises with alternating hypersecretion of E and DA. Patient 15 had severe hyper-and hypotensive crises with high E, DA, and NE secretion; Patient 17, hypertensive crises with elevated NE, E, and DA. Patients 15 and 17 had an extreme elevation of some conjugated CA. (The main  findings are summarized in table 2.) All pheochromocytomas were localized in the adrenal gland (in Patient 12, in an ectopic adrenal), and all patients improved after surgery; the patient with hyperplasia improved only temporarily after unilateral adrenalectomy. Two essential hypertensive patients (Patients 1 and 8) had higher urinary VMA and CA excretions and paroxysmal hypertension imitating pheochromocytoma following a stroke, a syndrome observed previously. 10 The other two patients with CA excretion in the normal range had similar pseudopheochromocytoma symptoms, probably related in one case (Patient 6) to the sympathetic discharge during coronary attacks 11 and in another (Patient 10) to typical orthostatic hypertension with hyperkinetic circulation similar to that described previously. 12 In none of the patients was renal function seriously affected, not even in the patient with the lowest creatinine clearance (62 ml/min) when related to the patient's age of 65 years.
Determination of plasma free and conjugated NE + E and DA obtained at several sites of sampling in essential hypertensive patients are summarized in table 3. The mean concentration of free and total NE + E in the inferior and superior vena cava was close to the concentration in the peripheral veins. The adrenal outflow contained a very high NE + E concentration (over 90% was E) that was 99% free. There were no differences in the degree of conjugation of NE and E in samples of NE and E determined separately, except in pheochromocytoma patients. Both the mean concentration and the percentage of free NE + E in the right renal venous outflow was lower than in the left renal vein, but the diffeence was not significant. The left renal vein also had a much higher content of free E (80%) than did the superior vena cava and peripheral blood (20%-25%). This reflects anatomical differences since the left adrenal vein is a tributary of the left renal vein, which contains a high amount of adrenal blood and consequently has a high E content. The suprarenal portion of the inferior vena cava contains more free NE + E than the infrarenal portion, while the total NE + E is not different. The mean total DA concentration in the left adrenal vein and its 15% free component is approximately double that of the DA values found at other sites of sampling where free DA is very low or undetectable.
A pheochromocytoma was eventually removed from six patients, and an adrenomedullary hyperplasia found in one. In patient 11, the pheochromocytoma in the right adrenal ( fig. 1 ) released approximately twice the amount of exclusively free NE + E into the right adrenal vein as that found in the patient's unaffected left side or in the adrenal venous blood of other patients with essential hypertension. The adrenal outflow of free DA on the side of the pheochromocytoma was also approximately double that of the unaffected side, the proportion of conjugated DA being slightly higher. The i.v. administration of 1 mg glucagon provoked an increase in blood pressure within 3 minutes from 140/70 to 210/110 mm Hg and an increase of free NE + E to 11.8 ng/ml, while no conjugated NE + E was detectable in the peripheral blood. Ten minutes after glucagon injection, the blood pressure decreased to 138/65, and both free and conjugated NE + E returned to concentrations close to the baseline (0.74 free and 1.38 ng/ml conjugated NE + E). During a spontaneous hypertensive paroxysm, approximately the same concentration of total NE + E appeared in plasma, but some of it was in conjugated form. After removal of the tumor, there were no blood pressure and CA responses to glucagon. Similar glucagon tests performed in 11 patients with essential hypertension resulted in a blood pressure increase from 140 ± 6/81 ± 3 to 151 ± 4/89 ± 5 (mean ± SEM) mm Hg and a change from normal plasma NE + E baseline values of 0.32 ± 0.04 (free) and 1.32 ± 0.3 ng/ml (conjugated) to 0.69 ± 0.07 (free) and 0.85 ± 0.28 (conjugated). This change occurred within 3 minutes and returned to 0.48 ±0.11 (free) and 1.21 ± 0.32 (conjugated) NE + E within 10 minutes.
Patient 12 had a pheochromocytoma in an ectopic adrenal tissue, close to the lower pole of the right kidney, supplied with blood through a branch of the right adrenal artery. Catheterization of the right adrenal vein was unsuccessful. The tumor was at least partly drained, however, by the right renal vein. It contained an elevated concentration of free NE + E (3 ng/ml), whereas there is usually less free NE + E in the right (approximately 1 ng/ml) than in the left renal vein (approximately 2.5 ng/ml). In Patient 12, total NE + E was very high (10-15 times normal) and mostly in conjugated form, even when blood pressure was normal (between 145/95 and 100/70 mm Hg) ( fig.  2) . To a lesser degree, conjugated DA was also elevated at all sites of sampling. The concentration of conjugated NE + E was highest in the arterial blood but lowest in the inferior vena cava.
Patient 13 had very high and exclusively free NE + E in the infrarenal inferior vena cava: 10.6 ng/ml for free NE + E (95% was NE) and 0.5 ng/ml for free DA. This was due to a pheochromocytoma that presented itself as a highly vascularized mass draining into the inferior vena cava. Patient 14 had a pheochromocytoma with a predominant hypersecretion of E and DA; both were released alternatively during spontaneous, predominantly normotensive paroxysms. The most evident feature of a normotensive crisis was a tenfold increase in free plasma DA (from 0.5 to 5.5 ng/ml) and an absence of conjugated DA, while in a hypertensive crisis the conjugated DA was 6.9 ng/ml. Free and conjugated E was persistently higher than free and conjugated NE but none of their changes could be correlated with the level of blood pressure. Six months after surgery, free CA and their response to glucagon were normal.
Patient 15 ( fig. 3 ) had spontaneous variations of blood pressure within 25 minutes, from extremely elevated to very low, a variable symptomatology that included headaches, palpitations, trembling, anxiety, weakness, sweating, and nausea, none of which could be precisely related to the hypertensive or hypotensive period. Pulse rate varied also between moderate tachycardia and occasional reflex bradycardia. This variable presentation was probably related to differences in circulating CA and their free and conjugated fractions. The high and low levels of blood pressure and pulse rate could not be related to any single free CA. When the mean of the three hypertensive and three hypotensive crises were compared, however, the most evident change that could be related to sudden hypotension was an increase in total (in this case, conjugated) DA resulting in a higher ratio of total DA to total NE (2.3 ± 0.3 during hypertension vs 6.9 ± 1 during hypotension,/? < 0.02). Two weeks postoperatively, this ratio remained elevated due to continuously elevated plasma total DA, while all other values returned close to normal.
Patient 16 had a highly positive glucagon test, namely, an increase of plasma free NE from 0.37 to 14.8 ng/ml and E from 1.1 to 2.5 ng/ml with a blood pressure increase from 129/61 to 251/? mm Hg 3 minutes after receiving glucagon. The right renal vein contained 1.13 ng/ml NE and 0.21 ng/ml E compared to 0.61 and 0.12 ng/ml on the left side when blood pressure was normal. This is the opposite of that seen in control patients, which suggests a pathological source of CA on the right side. Regional sampling with the catheter in place in the suprarenal inferior vena cava showed an increase of free NE from 0.64 to 6.66 ng/ml and free E from 0.31 to 1.61 ng/ml with a blood pressure increase from 145/69 to 248/70 mm Hg 3 minutes after glucagon administration. During baseline samplings and throughout these maneuvers, conjugated NE and E remained undetectable; plasma free DA low; and conjugated DA at the lower limit (0.46 ng/ml). During the crises, free DA increased (to 1.65 ng/ml) and conjugated DA became undetectable. Urinary excretion of free NE was very high. The patient improved when a right adrenal pheochromocytoma was eventually removed. Patient 17 had severe hypertensive paroxysms originally thought to be due to a pheochromocytoma of the bladder, since crises were often provoked by bladder distension. Selective catheterization revealed normal free but elevated conjugated CA at all sites of sampling. Use of CAT scanning suggested an increase of the volume of the left adrenal. Determinations of CA showed that even during normotension there was a very high level of conjugated plasma E (14.1 ng/ml) and to a less degree NE and DA (2.1, 3.1 ng/ml respectively), but the urinary excretion of VMA and free CA was normal except that free E excretion was elevated. During hypertensive periods, the increases of free CA themselves (NE from 0.2 to 0.3, E from 0.2 to 0.6, DA from 0.3 to 0.6 ng/ml) could not account for the hypertension. Conjugated NE was approximately six times higher (13.6 ng/ml) than during normal blood pressure, however, while conjugated E and conjugated DA increased only moderately to 19.8 and 6.5 ng/ml respectively; this resulted in a decreased ratio of total E to total NE (from'6.7 to 1.5). The exploration of the bladder remained negative but left total adrenalectomy led to a temporary disappearance of crises.
FIGURE 1. Pheochromocytoma of the right adrenal in Patient II. Upper left panel: Renal arteriography showing, in the arterial phase, a hypervascularized adrenal tumor supplied by the branches of the dilated inferior right adrenal artery. Upper right panel: In the parenchymatous phase, the tumor presents a homogenous, dense, clearly limited, and persistent tumor blush. Lower panel: The right adrenal vein contains elevated concentrations of exclusively free norepinephrine and epinephrine (NE + E) and a measurable proportion of free dopamine (DA). Concentrations in the left adrenal vein and the infrarenal inferior vena cava show only moderately higher levels of NE + E and DA (both free and conjugated) than in control essential hypertensive patients.
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The analysis for CA of the tumors of Patients 14 and 15 showed very high concentrations of E (25,895 and 25,022 jig/g tissue) and less NE (5716 and 5263 jtg/g tissue). Patient 16 had more NE (35,830 jtg/g tissue) than E (13, 190 Mg/g tissue). Histologically, all patients had typical adrenal pheochromocytomas except Patient 17 who had an adrenal medullary hyperplasia of the left adrenal similar to that previously described. 13 The left adrenal (weight 11 g, size 3.5 X 4 X 4 cm) had an abundant medulla with diffuse hyperplasia with some islets of medullary tissue penetrating into the otherwise normal adrenal cortical zones. Electron microscopy demonstrated polygonal cells containing granulation A (adrenaline) and N (noradrenaline) in Patient 14 and granulation A in Patient 15.* Measurements of individual CA in the venous outflow from the tumors showed extremely high values of free E (831 Mg/ml in Patient 14 and 5.9 Mg/ml in Patient 15) and less NE (43 ng/ml in Patient 14 and 14.3 ng/ml, 5% conjugated, in Patient 15). The determination of DA yielded very high values, but they were difficult to quantitate, both in the venous outflow and in the tumors, due to the cross reactivity with large amounts of E. In Patient 17, the adjacent adrenal venous concentrations of free and conjugated NE, E, and DA were not different from the mean concentrations observed in the group of patients with essential hypertension (19.3 ng/ml free E, 1.9 free NE, 0.5 free DA, and 3.8 conjugated DA). The concen- trations of free NE in Patients 14 and 15 were higher in the superior vena cava (103 and 24 ng/ml respectively) than in the venous outflow from the tumor (43 and 7.1 respectively). These concentrations decreased to 13 and 1.9 ng/ml respectively 35 minutes after removal of the tumor, despite the continuous stress of the operation. All the DA, NE, and E remained free in Patient 14 but was rapidly conjugated in Patient 15.
In the overall analysis of the peripheral plasma values available, there was an evident difference between Patients 11, 14, and 16 on one hand and Patients 12, 15, and 17 on the other. The first three patients had lower concentrations of plasma conjugates than the latter three patients (conjugated NE + E of 1.2 ± 0.3 vs 14 ± 3.1 ng/ml respectively,/? < 0.01; and conjugated DA of 3.2 ± 0.5 vs 9.7 ± 2.1 respectively, p < 0.05). The first three patients as well as Patient 13, whose peripheral plasma CA levels were not determined, also had urinary VMA excretion levels higher than the other three patients (between 17.3 and 72 vs 1.6 and 14.6 mg/day respectively,/; < 0.02). Another difference concerned the ratio of urinary free NE to E, with NE excretion four to six times higher than E in Patients 11, 12, and 16, but a predominance of E excretion in Patients 14 and 15, and approximately equal excretion of both CA in Patient 17.
Discussion
Regional venous measurements of free and conjugated CA in essential hypertensive patients indicate that CA (mainly E and to a lesser degree DA) are released in free form from the adrenal medulla and are conjugated during passage in the venous blood. This probably occurs in platelets containing the phenol sulfotransferase (PST), U the main sulfoconjugating enzyme in man, which has an approximately five-times-higher affinity for DA than for NE and E. The infrarenal portion of the inferior vena cava has concentrations of both free 15 and conjugated CA similar to those in the superior vena cava as previously observed. The slightly elevated plasma NE + E levels and higher percentage of free plasma NE + E (33%-59% compared to the normal 21%') are probably due to the stress of blood sampling. When a precaution was taken to avoid a venous puncture immediately preceding the blood sampling, hypertensive patients were found to have normal CA 1 ' and a normal ratio of free to conjugated CA. 17 The procedure does not appear to affect conjugated DA, since conjugated DA has been found to be elevated in essential hypertension whether blood is taken by direct puncture or by indwelling catheter.' It is difficult to evaluate the respective roles of hypertension and stress of procedure, however, since for ethical reasons no control subjects were subjected to catheterization. A recent report 18 showed, however, that there was no difference in free CA, determined after selective catheterization, between normotensive and essential hypertensive patients.
Against this background of findings in essential hypertension, patients with a pheochromocytoma were explored for an abnormal release and degradation of CA. During a typical paroxysm, diffusion across the plasma membrane was reported to be the predominant mechanism for CA release from a pheochromocytoma during a crisis 19 (in contrast to exocytosis occurring normally). This results in such a precipitous release of free CA into the inferior vena cava that the peripheral venous blood sometimes contains predominantly free CA at the height of the paroxysm. It is estimated that, normally, one passage through the liver decreases free CA to 20% of the original influx by combined action of COMT, MAO, and the conjugating enzymes. 20 Sulphoconjugation is known to be an enzymatic process that can be inhibited by the presence of a large amount of CA substrate. 14 The massive CA release from a pheochromocytoma can thus result in a sudden increase of free CA. After 10 minutes, free CA decrease and the normal ratio of free to conjugated CA is reestablished. Since the normal half-life of free NE in blood is less than 2 minutes, 21 the CA release from the tumor has to be massive and/or continuous in order to achieve such high peripheral levels at the height of the crisis.
While these secretory patterns were typical for the paroxysms in Patients 11 and 16 (for free NE and E), Patient 13 (probably for free NE), and Patient 14 (for free DA), Patients 12, 15, and 17 had very high peripheral venous conjugated CA (and Patient 12 twice as much in the artery) and did not show any changes in free CA that could be correlated per se with high, normal, or low blood pressure. It thus appears that conjugation was used less in Patients 11, 13, 14, and 16 as an inactivation pathway of CA than in the other 3 patients. The rapid appearance of conjugates 35 minutes after removal of the tumor in Patient 15, but their absence under the same conditions in Patient 14, also points to differences in conjugation activity. Patient 12, who had a high concentration of conjugated CA in venous and arterial blood, is probably an illustrative case: the very high conjugated CA in the suprarenal inferior vena cava traveled from the right to the left side of the heart after passage through the lung. 22 The venous concentration of conjugated CA decreased probably because of renal excretion and a higher distribution volume in the venous than in the arterial blood.
It is difficult to explain why Patients 12, 15, and 17 had such exceptionally high levels of conjugated CA. Their conjugation of CA may have taken preference over other metabolic pathways, as suggested by their lower VMA excretion. A rapid conjugation of the highly active free CA may thus explain the fact that Patients 12 and 17 had a blood pressure that was low and stable without treatment during the 14 days of observation as well as during the arteriography and catheterization. This is in contrast to the other patients with pheochromocytomas who each had at least three spontaneous hypertensive paroxysms during the same period. The high levels of conjugated circulating NE + E in Patients 12 and 17 may thus reflect a very active conjugating system, possibly induced by continuous rather than paroxysmic CA release. If such a modifying effect of high conjugated CA were confirmed in a larger sampling of patients, this change in the ratio of free to conjugated CA could become a marker of the conjugation, and as such, of the biologically active and inactive CA. We have previously reported 23 higher levels of plasma conjugated DA in pheochromocytomas at sampling sites other than that of the adjacent venous outflow. This suggests, together with the present data, that a high, continuous, autonomous secretion of CA may induce PST. Such a state appears to be reflected earlier by higher levels of conjugated DA than of conjugated NE and E due to the high affinity of PST to DA. M When one takes into account the type of CA secreted rather than its degree of conjugation, it appears that the predominant secretion of E and DA are more characteristic than the degree of conjugation itself for the normotensive or hypotensive crises that sometimes alternate in rapid sequence with hypertensive crises. It has been previously demonstrated that a pheochromocytoma with massive E " or DA secretion 25 usually results in normal blood pressure, since the final vascular action is a blend of a-, /3-, and dopaminergic effects. The DA-NE balance at the receptor site appears to be of importance for the final vascular response. 12 ' m The severe hypotensive crises in Patient 15 remained unexplained, however, by changes in free CA. Not only free but also elevated levels of conjugated CA may thus be of some biological relevance. The hypotensive crisis of Patient 15 on January 24 ( fig. 3 ) was associated with an extreme elevation of plasma conjugated DA, but that on January 27 with a decrease of the total free and conjugated NE. In this patient, exclusively free DA released from the tumor was rapidly conjugated, since during any type of crisis only 2%-9% of it could be detected in the peripheral blood as free. Although the CA involved appears thus to be of primary importance in determining the type of paroxysm, a possible additional role of the degree of CA conjugation remains to be investigated in a larger sampling of patients. Patient 17 is of particular interest if one considers the possibility that conjugated CA measurements may become diagnostic markers of adrenomedullary hyperfunction. This patient would have escaped detection if his conjugated CA had not been measured. He had normal free CA during crises and in the venous plasma adjacent to the suspected source of adrenomedullary hyperfunction, and an only unimpressive increase in urinary free E excretion.
The present data suggest that under extreme CA hypersecretion, measurements of conjugated (in addition to free) CA can help us understand their secretory and inactivation pathways. The wide spectrum of CA released, and the balance between their release and inactivation, contributes probably most to the enormous variability in the clinical presentation of pheochromocytomas. 27 The elevated levels of conjugated CA may reflect the preferential inactivation pathway better than other metabolites that are rapidly excreted; they may remain elevated for weeks and months as suggested by persistently high conjugated DA in two patients after the tumor has been removed. Measurement of conjugates is of particular interest in the case of DA, since free DA is usually below detection limits in control 1 and essential hypertensive subjects; 3 DA can be released in high concentrations into the circulation 25 but is so rapidly conjugated that it can be only exceptionally detected as free. Further study is required for the presently limited evidence that elevated levels of conjugated CA could be a marker of an asymptomatic adrenomedullary hyperfunction 28 
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